ArriVent BioPharma Inc — Dividend History & Yield (NASDAQ:AVBP) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Dividends per share — — Dividend yield % — — Payout ratio % — —

Notizie

Cantor Fitzgerald ribadisce il rating Overweight per le azioni ArriVent

ArriVent stock rating reiterated as Overweight by Cantor Fitzgerald

Oppenheimer conferma il rating Outperform per le azioni di ArriVent BioPharma

Oppenheimer reiterates Outperform rating on ArriVent BioPharma stock

ArriVent BioPharma (AVBP): Its Leading Asset, Furmonertinib, Supports A Cautious Buy

ArriVent BioPharma: A De-Risked Binary With Near-Term Catalysts (NASDAQ:AVBP)

Cantor Fitzgerald inizia la copertura di ArriVent BioPharma con rating Overweight

Cantor Fitzgerald initiates ArriVent BioPharma stock with Overweight rating

ArriVent dosa il primo paziente nello studio pivotale di fase 3 per farmaco contro il cancro al polmone

ArriVent doses first patient in pivotal phase 3 trial for lung cancer drug

ArriVent BioPharma: BTIG avvia copertura con rating Buy per potenziale oncologico

ArriVent BioPharma stock initiated with Buy rating at BTIG on oncology potential